{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:48:27Z","timestamp":1786686507541,"version":"build-2736575974"},"reference-count":52,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III, CIBERNED Spain","doi-asserted-by":"publisher","award":["CB06\/05\/004"],"award-info":[{"award-number":["CB06\/05\/004"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The effect that cytokines can exert on the progression from mild cognitive\nimpairment (MCI) to ongoing dementia is a matter of debate and the results obtained so far are controversial.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of the study is to analyze the influence of markers of subclinical inflammation on the progression of MCI to dementia.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A prospective study involving a cohort of patients \u2265 65 years of age diagnosed with MCI and followed for 3 years was conducted. 105 patients were enrolled, and serum concentrations of several subclinical inflammatory markers were determined.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>After 3.09 (2 - 3.79) years of follow-up, 47 (44.76%) patients progressed to dementia. Alpha 1-antichymotrypsin (ACT) was found to be significantly higher in patients who progressed to dementia (486.45 \u00b1 169.18 vs. 400.91 \u00b1 163.03; p = 0.012), and observed to significantly increase the risk of developing dementia in patients with mild cognitive impairment (1.004, 1.001-1.007; p= 0.007). IL-10 levels were significantly higher in those who remained stable (6.69 \u00b1 18.1 vs. 32.54 \u00b1 89.6; p = 0.04). Regarding the type of dementia to which our patients progressed, we found that patients who developed mixed dementia had higher IL-4 levels than those who converted to AD (31.54 \u00b1 63.6 vs. 4.43 \u00b1 12.9; p = 0.03). No significant differences were observed between the groups with regard to the ESR and LPa, CRP, IL-1 and TNF-\u03b1 levels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>ACT levels have a significant predictive value in the conversion of MCI to dementia. IL-10 levels could be a protective factor. It is necessary to conduct studies with serial determinations of these and other inflammatory markers in order to determine their effect on the progression of MCI to dementia.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205019666220127102640","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T08:10:06Z","timestamp":1643357406000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of Inflammatory Cytokines in the Conversion of Mild Cognitive Impairment\nto Dementia: A Prospective Study"],"prefix":"10.2174","volume":"19","author":[{"given":"Ra\u00fal","family":"Romero-Sevilla","sequence":"first","affiliation":[{"name":"Department of Neurology, Hospital Universitario de Caceres, C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"L\u00f3pez-Espuela","sequence":"additional","affiliation":[{"name":"Nursing Department. Nursing and Occupational Therapy College, University of Extremadura. C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular\nBiology and Genetics. Nursing and Occupational Therapy College, University of Extremadura, C\u00e1ceres, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas (CIBERNED) Madrid, Spain"},{"name":"Instituto Universitario de Investigaci\u00f3n Biosanitaria de Extremadura (INUBE), Caceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Duque","family":"de San Juan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario de Caceres, C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Portilla-Cuenca","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario de Caceres, C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen C\u00e1mara","family":"Hijon","sequence":"additional","affiliation":[{"name":"Servicio de Inmunolog\u00eda. Hospital Universitario de C\u00e1ceres, C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Casado-Naranjo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario de Caceres, C\u00e1ceres, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas (CIBERNED) Madrid, Spain"},{"name":"Instituto Universitario de Investigaci\u00f3n Biosanitaria de Extremadura (INUBE), Caceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"World Health Organization, Alzheimer\u2019s Disease International Dementia: A Public Health Priority. 2015. ISBN: 9789241564458."},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Hou Y.","year":"2019","unstructured":"Hou Y.; Dan X.; Babbar M.; Wei Y.; Hasselbalch S.G.; Croteau D.L.; Bohr V.A.; Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 2019,15(10),565-581","journal-title":"Nat Rev Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12068","year":"2020","unstructured":"2020 Alzheimer\u00b4s disease facts and figures. Alzheimers Dement 16(3): 391-460.2020","journal-title":"Alzheimers Dement"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jalz.2011.01.002","volume":"8","author":"Ward A.","year":"2012","unstructured":"Ward A.; Arrighi H.M.; Michels S.; Cedarbaum J.M.; Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement 2012,8(1),14-21","journal-title":"Alzheimers Dement"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cger.2018.06.005","volume":"34","author":"Tangalos E.G.","year":"2018","unstructured":"Tangalos E.G.; Petersen R.C.; Mild cognitive impairment in geriatrics. Clin Geriatr Med 2018,34(4),563-589","journal-title":"Clin Geriatr Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00415-011-6342-0","volume":"259","author":"Li L.","year":"2012","unstructured":"Li L.; Wang Y.; Yan J.; Chen Y.; Zhou R.; Yi X.; Shi Q.; Zhou H.; Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study. J Neurol 2012,259(7),1303-1311","journal-title":"J Neurol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/jnnp.2008.171066","volume":"81","author":"Nordlund A.","year":"2010","unstructured":"Nordlund A.; Rolstad S.; Klang O.; Edman A.; Hansen S.; Wallin A.; Two-year outcome of MCI subtypes and aetiologies in the G\u00f6teborg MCI study. J Neurol Neurosurg Psychiatry 2010,81(5),541-546","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/jnnp.2010.217778","volume":"10","author":"Mitchell A.J.","year":"2010","unstructured":"Mitchell A.J.; Monge-Argil\u00e9s J.A.; S\u00e1nchez-Paya J.; Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia? Pract Neurol 2010,10(4),202-207","journal-title":"Pract Neurol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000093101","volume":"22","author":"Alexopoulos P.","year":"2006","unstructured":"Alexopoulos P.; Grimmer T.; Perneczky R.; Domes G.; Kurz A.; Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 2006,22(1),27-34","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","volume":"367","author":"Gauthier S.","year":"2006","unstructured":"Gauthier S.; Reisberg B.; Zaudig M.; Petersen R.C.; Ritchie K.; Broich K.; Belleville S.; Brodaty H.; Bennett D.; Chertkow H.; Cummings J.L.; de Leon M.; Feldman H.; Ganguli M.; Hampel H.; Scheltens P.; Tierney M.C.; Whitehouse P.; Winblad B.; Mild cognitive impairment. Lancet 2006,367(9518),1262-1270","journal-title":"Lancet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1136\/jnnp.2010.231555","volume":"82","author":"Elias-Sonnenschein L.S.","year":"2011","unstructured":"Elias-Sonnenschein L.S.; Viechtbauer W.; Ramakers I.H.; Verhey F.R.; Visser P.J.; Predictive value of APOE-\u03b54 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry 2011,82(10),1149-1156","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1161\/01.STR.0000143318.70292.47","volume":"35","author":"Gorelick P.B.","year":"2004","unstructured":"Gorelick P.B.; Risk factors for vascular dementia and Alzheimer disease. Stroke 2004,35(11),2620-2622","journal-title":"Stroke"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1176\/appi.ajp.2014.14070878","volume":"172","author":"Cooper C.","year":"2015","unstructured":"Cooper C.; Sommerlad A.; Lyketsos C.G.; Livingston G.; Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry 2015,172(4),323-334","journal-title":"Am J Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1874205X01509010009","volume":"9","author":"Kamat P.K.","year":"2015","unstructured":"Kamat P.K.; Vacek J.C.; Kalani A.; Tyagi N.; Homocysteine induced cerebrovascular dysfunction: a link to Alzheimer\u2019s disease etiology. Open Neurol J 2015,9,9-14","journal-title":"Open Neurol J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/ane.12525","volume":"134","author":"Casado-Naranjo I.","year":"2016","unstructured":"Casado-Naranjo I.; Romero Sevilla R.; Portilla Cuenca J.C.; Duque de San Juan B.; Calle Escobar M.L.; Fern\u00e1ndez Pereira L.; Fuentes J.M.; Ram\u00edrez-Moreno J.M.; Association between subclinical carotid atherosclerosis, hyperhomocysteinaemia and mild cognitive impairment. Acta Neurol Scand 2016,134(2),154-159","journal-title":"Acta Neurol Scand"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1161\/STROKEAHA.109.557280","volume":"40","author":"Wendell C.R.","year":"2009","unstructured":"Wendell C.R.; Zonderman A.B.; Metter E.J.; Najjar S.S.; Waldstein S.R.; Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009,40(10),3180-3185","journal-title":"Stroke"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JAD-2010-090700","volume":"23","author":"Mazza M.","year":"2011","unstructured":"Mazza M.; Marano G.; Traversi G.; Bria P.; Mazza S.; Primary cerebral blood flow deficiency and Alzheimer\u2019s disease: shadows and lights. J Alzheimers Dis 2011,23(3),375-389","journal-title":"J Alzheimers Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri.2016.123","volume":"17","author":"Becher B.","year":"2017","unstructured":"Becher B.; Spath S.; Goverman J.; Cytokine networks in neuroinflammation. Nat Rev Immunol 2017,17(1),49-59","journal-title":"Nat Rev Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/1567205014666170317113606","volume":"14","author":"Domingues C.","year":"2017","unstructured":"Domingues C.; da Cruz E Silva O.A.B.; Henriques A.G.; Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological hallmarks. Curr Alzheimer Res 2017,14(8),870-882","journal-title":"Curr Alzheimer Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1567205016666190321154618","volume":"16","author":"Paouri E.","year":"2019","unstructured":"Paouri E.; Georgopoulos S.; Systemic and CNS inflammation crosstalk: implications for Alzheimer\u2019s disease. Curr Alzheimer Res 2019,16(6),559-574","journal-title":"Curr Alzheimer Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2174\/156720501711210101110513","volume":"17","author":"Fakhoury M.","year":"2020","unstructured":"Fakhoury M.; Inflammation in Alzheimer\u2019s disease. Curr Alzheimer Res 2020,17(11),959-961","journal-title":"Curr Alzheimer Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41598-020-59869-5","volume":"10","author":"Friedberg J.S.","year":"2020","unstructured":"Friedberg J.S.; Aytan N.; Cherry J.D.; Xia W.; Standring O.J.; Alvarez V.E.; Nicks R.; Svirsky S.; Meng G.; Jun G.; Ryu H.; Au R.; Stein T.D.; Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E \u03b54 genotype. Sci Rep 2020,10(1),2924","journal-title":"Sci Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0197-4580(01)00302-5","volume":"22","author":"Abraham C.R.","year":"2001","unstructured":"Abraham C.R.; Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer\u2019s disease. Neurobiol Aging 2001,22(6),931-936","journal-title":"Neurobiol Aging"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1073\/pnas.92.6.2313","volume":"92","author":"Eriksson S.","year":"1995","unstructured":"Eriksson S.; Janciauskiene S.; Lannfelt L.; Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc Natl Acad Sci USA 1995,92(6),2313-2317","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1093\/brain\/awl255","volume":"129","author":"Padmanabhan J.","year":"2006","unstructured":"Padmanabhan J.; Levy M.; Dickson D.W.; Potter H.; Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer\u2019s disease brain, induces tau phosphorylation in neurons. Brain 2006,129(Pt 11),3020-3034","journal-title":"Brain"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"Calsolaro V.","year":"2016","unstructured":"Calsolaro V.; Edison P.; Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future\u00a0directions. Alzheimers Dement 2016,12(6),719-732","journal-title":"Alzheimers Dement"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","volume":"11","author":"Hampel H.","year":"2020","unstructured":"Hampel H.; Caraci F.; Cuello A.C.; Caruso G.; Nistic\u00f2 R.; Corbo M.; Baldacci F.; Toschi N.; Garaci F.; Chiesa P.A.; Verdooner S.R.; Akman-Anderson L.; Hern\u00e1ndez F.; \u00c1vila J.; Emanuele E.; Valenzuela P.L.; Luc\u00eda A.; Watling M.; Imbimbo B.P.; Vergallo A.; Lista S.; A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer\u2019s disease. Front Immunol 2020,11,456","journal-title":"Front Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2018.02.015","volume":"347","author":"Swanson A.","year":"2018","unstructured":"Swanson A.; Wolf T.; Sitzmann A.; Willette A.A.; Neuroinflammation in Alzheimer\u2019s disease: Pleiotropic roles for cytokines and neuronal pentraxins. Behav Brain Res 2018,347,49-56","journal-title":"Behav Brain Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"Doecke J.D.","year":"2012","unstructured":"Doecke J.D.; Laws S.M.; Faux N.G.; Wilson W.; Burnham S.C.; Lam C.P.; Mondal A.; Bedo J.; Bush A.I.; Brown B.; De Ruyck K.; Ellis K.A.; Fowler C.; Gupta V.B.; Head R.; Macaulay S.L.; Pertile K.; Rowe C.C.; Rembach A.; Rodrigues M.; Rumble R.; Szoeke C.; Taddei K.; Taddei T.; Trounson B.; Ames D.; Masters C.L.; Martins R.N.; Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 2012,69(10),1318-1325","journal-title":"Arch Neurol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","volume":"69","author":"Soares H.D.","year":"2012","unstructured":"Soares H.D.; Potter W.Z.; Pickering E.; Kuhn M.; Immermann F.W.; Shera D.M.; Ferm M.; Dean R.A.; Simon A.J.; Swenson F.; Siuciak J.A.; Kaplow J.; Thambisetty M.; Zagouras P.; Koroshetz W.J.; Wan H.I.; Trojanowski J.Q.; Shaw L.M.; Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol 2012,69(10),1310-1317","journal-title":"Arch Neurol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD-141770","volume":"44","author":"Casado Naranjo I.","year":"2015","unstructured":"Casado Naranjo I.; Portilla Cuenca J.C.; Duque de San Juan B.; Garc\u00eda A.F.; Sevilla R.R.; Serrano Cabrera A.; Hij\u00f3n C.C.; Romero Chala S.; Fuentes J.M.; Ram\u00edrez Moreno J.M.; Association of vascular factors and amnestic mild cognitive impairment: a comprehensive approach. J Alzheimers Dis 2015,44(2),695-704","journal-title":"J Alzheimers Dis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"Winblad B.","year":"2004","unstructured":"Winblad B.; Palmer K.; Kivipelto M.; Jelic V.; Fratiglioni L.; Wahlund L.O.; Nordberg A.; B\u00e4ckman L.; Albert M.; Almkvist O.; Arai H.; Basun H.; Blennow K.; de Leon M.; DeCarli C.; Erkinjuntti T.; Giacobini E.; Graff C.; Hardy J.; Jack C.; Jorm A.; Ritchie K.; van Duijn C.; Visser P.; Petersen R.C.; Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004,256(3),240-246","journal-title":"J Intern Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti K.G.","year":"2009","unstructured":"Alberti K.G.; Eckel R.H.; Grundy S.M.; Zimmet P.Z.; Cleeman J.I.; Donato K.A.; Fruchart J.C.; James W.P.; Loria C.M.; Smith S.C.; Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009,120(16),1640-1645","journal-title":"Circulation"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"Folstein M.F.","year":"1975","unstructured":"Folstein M.F.; Folstein S.E.; McHugh P.R.; \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975,12(3),189-198","journal-title":"J Psychiatr Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1300\/J018v05n01_09","volume":"5","author":"Sheikh K.H.","year":"1986","unstructured":"Sheikh K.H.; Yesavage J.A.; Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986,5,165-173","journal-title":"Clin Gerontol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"Pfeffer R.I.","year":"1982","unstructured":"Pfeffer R.I.; Kurosaki T.T.; Harrah C.H.; Chance J.M.; Filos S.; Measurement of functional activities in older adults in the community. J Gerontol 1982,37(3),323-329","journal-title":"J Gerontol"},{"key":"ref=37","year":"1994","unstructured":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV American Psychiatric Association1994","journal-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"McKhann G.M.","year":"2011","unstructured":"McKhann G.M.; Knopman D.S.; Chertkow H.; Hyman B.T.; Jack C.R.; Kawas C.H.; Klunk W.E.; Koroshetz W.J.; Manly J.J.; Mayeux R.; Mohs R.C.; Morris J.C.; Rossor M.N.; Scheltens P.; Carrillo M.C.; Thies B.; Weintraub S.; Phelps C.H.; The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 2011,7(3),263-269","journal-title":"Alzheimers Dement"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"Rom\u00e1n G.C.","year":"1993","unstructured":"Rom\u00e1n G.C.; Tatemichi T.K.; Erkinjuntti T.; Cummings J.L.; Masdeu J.C.; Garcia J.H.; Amaducci L.; Orgogozo J.M.; Brun A.; Hofman A.; Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993,43(2),250-260","journal-title":"Neurology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/S1041610203008949","volume":"15","author":"Rockwood K.","year":"2003","unstructured":"Rockwood K.; Mixed dementia: Alzheimer\u2019s and cerebrovascular disease. Int Psychogeriatr 2003,15,39-46","journal-title":"Int Psychogeriatr"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fpsyt.2018.00606","volume":"9","author":"Kim J.W.","year":"2018","unstructured":"Kim J.W.; Stewart R.; Kang H.J.; Bae K.Y.; Kim S.W.; Shin I.S.; Yoon J.S.; Kim J.M.; Longitudinal Associations Between Serum Cytokine Levels and Dementia. Front Psychiatry 2018,9,606","journal-title":"Front Psychiatry"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00002093-199509020-00009","volume":"9","author":"Licastro F.","year":"1995","unstructured":"Licastro F.; Parnetti L.; Morini M.C.; Davis L.J.; Cucinotta D.; Gaiti A.; Senin U.; Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Dis Assoc Disord 1995,9(2),112-118","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","volume":"64","author":"Dik M.G.","year":"2005","unstructured":"Dik M.G.; Jonker C.; Hack C.E.; Smit J.H.; Comijs H.C.; Eikelenboom P.; Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005,64(8),1371-1377","journal-title":"Neurology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.10414","volume":"53","author":"DeKosky S.T.","year":"2003","unstructured":"DeKosky S.T.; Ikonomovic M.D.; Wang X.; Farlow M.; Wisniewski S.; Lopez O.L.; Becker J.T.; Saxton J.; Klunk W.E.; Sweet R.; Kaufer D.I.; Kamboh M.I.; Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer\u2019s disease: correlation with cognitive impairment. Ann Neurol 2003,53(1),81-90","journal-title":"Ann Neurol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"Brosseron F.","year":"2014","unstructured":"Brosseron F.; Krauthausen M.; Kummer M.; Heneka M.T.; Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol 2014,50(2),534-544","journal-title":"Mol Neurobiol"},{"key":"ref=46","first-page":"1005","volume":"12","author":"Wyss-Coray T.","year":"2006","unstructured":"Wyss-Coray T.; Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006,12(9),1005-1015","journal-title":"Nat Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","volume":"89","author":"King E.","year":"2018","unstructured":"King E.; O\u2019Brien J.T.; Donaghy P.; Morris C.; Barnett N.; Olsen K.; Martin-Ruiz C.; Taylor J.P.; Thomas A.J.; Peripheral inflammation in prodromal Alzheimer\u2019s and Lewy body dementias. J Neurol Neurosurg Psychiatry 2018,89(4),339-345","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-2009-1126","volume":"18","author":"Sundel\u00f6f J.","year":"2009","unstructured":"Sundel\u00f6f J.; Kilander L.; Helmersson J.; Larsson A.; R\u00f6nnemaa E.; Degerman-Gunnarsson M.; Basun H.; Lannfelt L.; Basu S.; Systemic inflammation and the risk of Alzheimer\u2019s disease and dementia: a prospective population-based study. J Alzheimers Dis 2009,18(1),79-87","journal-title":"J Alzheimers Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/jgs.12994","volume":"62","author":"Wichmann M.A.","year":"2014","unstructured":"Wichmann M.A.; Cruickshanks K.J.; Carlsson C.M.; Chappell R.; Fischer M.E.; Klein B.E.; Klein R.; Tsai M.Y.; Schubert C.R.; Long-term systemic inflammation and cognitive impairment in a population-based cohort. J Am Geriatr Soc 2014,62(9),1683-1691","journal-title":"J Am Geriatr Soc"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/gerona\/gls187","volume":"68","author":"Koyama A.","year":"2013","unstructured":"Koyama A.; O\u2019Brien J.; Weuve J.; Blacker D.; Metti A.L.; Yaffe K.; The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 2013,68(4),433-440","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","volume":"117","author":"Bermejo P.","year":"2008","unstructured":"Bermejo P.; Mart\u00edn-Arag\u00f3n S.; Bened\u00ed J.; Sus\u00edn C.; Felici E.; Gil P.; Ribera J.M.; Villar A.M.; Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease. Immunol Lett 2008,117(2),198-202","journal-title":"Immunol Lett"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"Darweesh S.K.L.","year":"2018","unstructured":"Darweesh S.K.L.; Wolters F.J.; Ikram M.A.; de Wolf F.; Bos D.; Hofman A.; Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: A meta-analysis. Alzheimers Dement 2018,14(11),1450-1459","journal-title":"Alzheimers Dement"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220127102640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200570\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220127102640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T21:26:42Z","timestamp":1691789202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200570\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205019666220127102640","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}